Orient Bio reports US$89.9m annual sales, 100m operating profit

11:31
[From the Scene] Immersive heritage exhibition opens in Gangneung, Las Vegas
10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap

Orient Bio reports US$89.9m annual sales, 100m operating profit

June 29, 2016 - 16:45 By 황유미

[DISCLOSURE] Orient Bio (002630) reported on June 29 that between April 2015 and March 2016 it posted sales of 105 billion won (US$89.9 million) and 100 million in operating profit. The pharmaceutical company recorded 2.5 billion won net loss for the fiscal year.

황유미